Mode
Text Size
Log in / Sign up

Oncology

1582 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Case report highlights diagnostic challenges between POEMS syndrome and CIDP
Oncology Sys. Review
Case report highlights diagnostic challenges between POEMS syndrome and CIDP Misdiagnosis of rare nerve disorder highlights need for vigilance
This case report and literature review describes a single patient with POEMS syndrome who was initially misdiagnosed with CIDP.
A single patient's journey from a wrong diagnosis to the truth reveals how easily rare nerve conditions can be missed.
Symptom Network Changes in Differentiated Thyroid Cancer Patients Undergoing Radioactive Iodine Therapy
Oncology Cohort
Symptom Network Changes in Differentiated Thyroid Cancer Patients Undergoing Radioactive Iodine Therapy Radioactive iodine therapy changes how symptoms connect in patients
This prospective cohort study of 520 patients with differentiated thyroid cancer found that radioactive iodine therapy significantly reorgan…
New research shows that radioactive iodine therapy reshapes how physical and psychological symptoms interact in people with thyroid cancer.
Deep hyperthermia with tislelizumab and chemotherapy in advanced squamous NSCLC
Oncology Cohort
Deep hyperthermia with tislelizumab and chemotherapy in advanced squamous NSCLC Deep Heat Plus Drug Boosts Lung Cancer Response Rates
This retrospective cohort study of 100 patients with advanced squamous NSCLC evaluated deep hyperthermia combined with tislelizumab and chem…
Adding deep heat to standard lung cancer treatment improved response rates significantly while keeping safety levels the same as standard ch…
AI-mediated ultrasonic radiomics shows potential for triple-negative breast cancer diagnosis and prognosis
Oncology Cohort
AI-mediated ultrasonic radiomics shows potential for triple-negative breast cancer diagnosis and prognosis AI tools show promise for triple negative breast cancer
This review of research progress examines AI-mediated ultrasonic radiomics for patients with triple-negative breast cancer (TNBC).
New AI methods using ultrasound images may help doctors better identify and predict how triple negative breast cancer might progress.
New SMART design improves efficiency in adaptive clinical trials
Oncology RCT
New SMART design improves efficiency in adaptive clinical trials New trial designs help doctors tailor treatment plans to fit each patient better
This methods study introduces response-adaptive tailoring function SMART (RA-TF-SMART) designs.
A new trial design helps doctors adjust treatment plans as patients respond, offering a smarter way to manage complex health needs.
Trastuzumab emtansine and trastuzumab deruxtecan use in three patients with ERBB2-amplified rare tumors
Oncology Cohort
Trastuzumab emtansine and trastuzumab deruxtecan use in three patients with ERBB2-amplified rare tumors Rare tumors respond to targeted antibody drug treatments
This retrospective case series evaluated three patients with ERBB2-amplified rare tumors, including periampullary, salivary duct, and poorly…
Three patients with rare, aggressive cancers saw significant tumor shrinkage after receiving targeted antibody drug therapies.
Observational study identifies four immune subtypes in newly-diagnosed glioma grades 2-4 among 354 patients
Oncology
Observational study identifies four immune subtypes in newly-diagnosed glioma grades 2-4 among 354 patients New immune map shows how glioma types affect survival chances
This primary research article describes an observational study of 354 patients with newly-diagnosed glioma grades 2-4.
A new map of immune cells in brain tumors reveals four types that predict survival and guide future treatment choices for patients.
Review of observational data on non-sedated MRI feasibility in newly diagnosed ALL patients ages 3 to 10 years
Oncology
Review of observational data on non-sedated MRI feasibility in newly diagnosed ALL patients ages 3 to 10 years Non-sedated MRI scans work for young leukemia patients with practice
This review synthesizes observational data from a community setting involving 17 newly diagnosed ALL patients and 30 controls ages 3 to 10 y…
Young children with acute lymphoblastic leukemia can undergo non-sedated MRI scans. Success rates improve with repeated visits and behaviora…
Network meta-analysis of pharmacological interventions for hand-foot syndrome in cancer patients undergoing chemotherapy
Oncology Meta-analysis
Network meta-analysis of pharmacological interventions for hand-foot syndrome in cancer patients undergoing chemotherapy Simple cream could stop painful hand and foot syndrome side effects
This network meta-analysis evaluated pharmacological interventions for hand-foot syndrome prevention in cancer patients undergoing chemother…
New research suggests a common pain cream could protect cancer patients from painful hand and foot syndrome during treatment.
CPX-351 improves survival in AML with myelodysplasia-related changes
Oncology RCT
CPX-351 improves survival in AML with myelodysplasia-related changes New leukemia treatment works best for specific gene type
This randomized phase 3 trial in 184 patients with AML and myelodysplasia-related mutations evaluated CPX-351 versus standard cytarabine plu…
A leukemia drug thought to help many patients actually works only in those with a specific genetic subtype, leaving others in need of better…
Mirtazapine and olanzapine reduce anxiety and depression scores in oral cavity cancer patients
Oncology RCT
Mirtazapine and olanzapine reduce anxiety and depression scores in oral cavity cancer patients Two Common Pills Ease Cancer Anxiety and Depression
This randomized controlled trial included 144 patients with oral cavity cancer.
Two well-known antidepressants significantly eased anxiety and depression in oral cancer patients, with mirtazapine showing a slight edge.
Meta-analysis of CD38-directed CAR-T therapy in relapsed refractory multiple myeloma reports high response rates
Oncology Meta-analysis
Meta-analysis of CD38-directed CAR-T therapy in relapsed refractory multiple myeloma reports high response rates New CD38 CAR-T therapy shows high success rates for late-stage multiple myeloma patients
This systematic review and meta-analysis evaluated CD38-directed CAR-T cell therapy in patients with relapsed refractory multiple myeloma.
A new immune therapy targeting CD38 and BCMA offers deep remission for late-stage multiple myeloma patients while managing side effects like…